Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study
Titel:
Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study
Auteur:
Brana, Irene Calles, Antonio LoRusso, Patricia M. Yee, Lorrin K. Puchalski, Thomas A. Seetharam, Shobha Zhong, Bob Boer, Carla J. de Tabernero, Josep Calvo, Emiliano